These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 15894263)
1. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Zhou H; Du MQ; Dixit VM Cancer Cell; 2005 May; 7(5):425-31. PubMed ID: 15894263 [TBL] [Abstract][Full Text] [Related]
2. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma. Hosokawa Y Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920 [TBL] [Abstract][Full Text] [Related]
3. Non-canonical NF-κB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2. Conze DB; Zhao Y; Ashwell JD PLoS Biol; 2010 Oct; 8(10):e1000518. PubMed ID: 21048983 [TBL] [Abstract][Full Text] [Related]
4. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma. Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249 [TBL] [Abstract][Full Text] [Related]
5. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB. Garrison JB; Samuel T; Reed JC Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489 [TBL] [Abstract][Full Text] [Related]
6. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2. Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304 [TBL] [Abstract][Full Text] [Related]
7. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391 [TBL] [Abstract][Full Text] [Related]
8. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions. Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209 [TBL] [Abstract][Full Text] [Related]
9. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810 [TBL] [Abstract][Full Text] [Related]
10. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443 [TBL] [Abstract][Full Text] [Related]
11. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21). Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317 [TBL] [Abstract][Full Text] [Related]
12. A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment. Lucas PC; Kuffa P; Gu S; Kohrt D; Kim DS; Siu K; Jin X; Swenson J; McAllister-Lucas LM Oncogene; 2007 Aug; 26(38):5643-54. PubMed ID: 17334391 [TBL] [Abstract][Full Text] [Related]
13. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling. Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773 [TBL] [Abstract][Full Text] [Related]
14. Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. Baens M; Fevery S; Sagaert X; Noels H; Hagens S; Broeckx V; Billiau AD; De Wolf-Peeters C; Marynen P Cancer Res; 2006 May; 66(10):5270-7. PubMed ID: 16707452 [TBL] [Abstract][Full Text] [Related]
15. MALT lymphoma: many roads lead to nuclear factor-κb activation. Du MQ Histopathology; 2011 Jan; 58(1):26-38. PubMed ID: 21261681 [TBL] [Abstract][Full Text] [Related]
16. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Zhou H; Wertz I; O'Rourke K; Ultsch M; Seshagiri S; Eby M; Xiao W; Dixit VM Nature; 2004 Jan; 427(6970):167-71. PubMed ID: 14695475 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism. Hamoudi RA; Appert A; Ye H; Ruskone-Fourmestraux A; Streubel B; Chott A; Raderer M; Gong L; Wlodarska I; De Wolf-Peeters C; MacLennan KA; de Leval L; Isaacson PG; Du MQ Leukemia; 2010 Aug; 24(8):1487-97. PubMed ID: 20520640 [TBL] [Abstract][Full Text] [Related]
18. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling. Klein T; Fung SY; Renner F; Blank MA; Dufour A; Kang S; Bolger-Munro M; Scurll JM; Priatel JJ; Schweigler P; Melkko S; Gold MR; Viner RI; Régnier CH; Turvey SE; Overall CM Nat Commun; 2015 Nov; 6():8777. PubMed ID: 26525107 [TBL] [Abstract][Full Text] [Related]
19. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Sun L; Deng L; Ea CK; Xia ZP; Chen ZJ Mol Cell; 2004 May; 14(3):289-301. PubMed ID: 15125833 [TBL] [Abstract][Full Text] [Related]
20. cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. Hu S; Du MQ; Park SM; Alcivar A; Qu L; Gupta S; Tang J; Baens M; Ye H; Lee TH; Marynen P; Riley JL; Yang X J Clin Invest; 2006 Jan; 116(1):174-81. PubMed ID: 16395405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]